These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1132185)

  • 21. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
    Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
    Podjarny E; Rathaus M; Korzets Z; Blum M; Zevin D; Bernheim J
    Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.
    Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG
    Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Parathyroidectomy for secondary hyperparathyroidism in renal insufficiency].
    Corvilain J; Fuss M; Kinnaert P; Moermans JP; Toussaint C; Van Geertruyden JV; Vereerstraeten P
    J Urol Nephrol (Paris); 1976; 82(4-5):362-7. PubMed ID: 781303
    [No Abstract]   [Full Text] [Related]  

  • 26. 22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
    Monier-Faugere MC; Geng Z; Friedler RM; Qi Q; Kubodera N; Slatopolsky E; Malluche HH
    Kidney Int; 1999 Mar; 55(3):821-32. PubMed ID: 10027919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid acidosis in uraemia.
    Muldowney FP; Donohoe JF; Carroll DV; Powell D; Freaney R
    Q J Med; 1972 Jul; 41(163):321-42. PubMed ID: 5072056
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.
    Lopez-Hilker S; Galceran T; Chan YL; Rapp N; Martin KJ; Slatopolsky E
    J Clin Invest; 1986 Oct; 78(4):1097-102. PubMed ID: 3760186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone regulation in normal and uremic rats. Reversibility of secondary hyperparathyroidism after experimental kidney transplantation.
    Lewin E
    Dan Med Bull; 2004 May; 51(2):184-206. PubMed ID: 16009056
    [No Abstract]   [Full Text] [Related]  

  • 30. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secondary hyperparathyroidism in chronic renal failure. Role of subtotal parathyroidectomy].
    Tarquini A; Nicolosi A; Massidda B; Bolasco P; Altieri P; Massidda C
    Minerva Chir; 1991 May; 46(10):501-6. PubMed ID: 1922866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
    Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
    Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An exceedingly rare localization of a brown tumor in a hemodialysis patient.
    Karagoz A; Turkmen K; Yazici R; Arslan S; Baktık S; Karanis MI; Altintepe L; Guney I
    Hemodial Int; 2013 Oct; 17(4):660-3. PubMed ID: 23216908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orbital involvement in craniofacial brown tumors.
    Cecchetti DF; Paula SA; Cruz AA; Lucca L; Nogueira-Barbosa MH; Chahud F; Conti-Freitas LC; Melo CB
    Ophthalmic Plast Reconstr Surg; 2010; 26(2):106-11. PubMed ID: 20305510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early radiographic manifestations of secondary hyperparathyroidism associated with chronic renal disease.
    Jensen PS; Kliger AS
    Radiology; 1977 Dec; 125(3):645-52. PubMed ID: 928688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
    Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
    BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Monstrous tumourous changes of the facial bones in secondary hyperparathyroidism (author's transl)].
    Pfeifle J; Koch H; Grabensee B; Knieriem HI
    Dtsch Med Wochenschr; 1974 Mar; 99(9):389-91. PubMed ID: 4828634
    [No Abstract]   [Full Text] [Related]  

  • 39. Total parathyroidectomy and autotransplantation of parathyroid tissue for renal hyperparathyroidism. A one- to six-year follow-up.
    Rothmund M; Wagner PK
    Ann Surg; 1983 Jan; 197(1):7-16. PubMed ID: 6848057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total parathyroidectomy and autotransplantation.
    Diaz-Buxo JA; Geissinger WT; Walker PJ; Chandler JT; Farmer CD; Holt KL; Wolfe P
    Clin Nephrol; 1981 Dec; 16(6):276-82. PubMed ID: 7318261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.